Recruiting

Creative Arts Program to Reduce Burnout in Healthcare Professionals

This study plans to learn if creative arts programs that include visual, musical, written, or physical expression can reduce symptoms of burnout syndrome, Post Traumatic Stress Disorder (PTSD), depression, and anxiety in critical care healthcare professionals. This study also explores if creative arts can enhance the connection to the purpose of work, the development of adequate coping skills, while providing time to connect with peers.

ClinicalTrials.gov IDNCT04276922
PhaseNA
Enrollment195
SponsorUniversity of Colorado, Denver
Age18 Years
SexALL
I'm interested View official listing

Conditions studied

Burn-Out Syndrome, Post-Traumatic Stress Disorder, Depression, Anxiety

About this study

This study plans to learn if creative arts programs that include visual, musical, written, or physical expression can reduce symptoms of burnout syndrome, Post Traumatic Stress Disorder (PTSD), depression, and anxiety in critical care healthcare professionals. This study also explores if creative arts can enhance the connection to the purpose of work, the development of adequate coping skills, while providing time to connect with peers.

Interventions

Primary outcomes

Eligibility information

Inclusion Criteria: * Employed as a healthcare provider, practicing primarily in a hospital setting for at least 20 hours per week. * Positive symptoms of burnout measured via the Maslach Burnout Inventory (MBI): * emotional exhaustion score of \>17, or * depersonalization score of \>7, or * personal accomplishment score of \< 31. Exclusion Criteria: • Unwillingness to participate in any of the four creative arts interventions.

Study locations

Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.

Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.